Mercer Global Advisors’s CareDx CDNA Stock Holding History
Bought
Maintained
Sold
Other funds holding CDNA
DM
AIM
GS
Mercer Global Advisors's CDNA Position: Q2 2026 in Review
Mercer Global Advisors increased its CareDx (CDNA) stake by 3.5% in Q2 2026, buying an estimated $9.54K and bringing the position to 13,122 shares worth $374K. The position accounts for ﹤0.01% of the portfolio, ranked #2578.
Mercer Global Advisors first reported a position in CDNA in Q2 2025 and has held it in 3 quarters since. The position peaked at $434K in Q2 2025. 227 funds tracked by Wall St. Rank hold CDNA as of Q2 2026.
- Mercer Global Advisors held 13,122 shares of CareDx worth $374K as of Q2 2026.
- Mercer Global Advisors bought 438 CareDx shares in Q2 2026, an estimated $9.54K.
- CareDx made up ﹤0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #2578 holding.
- Mercer Global Advisors first reported a position in CareDx in Q2 2025 and has held it in 3 quarters since.
- Mercer Global Advisors's CareDx position peaked at $434K in Q2 2025.
- 227 funds tracked by Wall St. Rank held CareDx as of Q2 2026.
Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.